Elizabeth Bayliss to Dementia
This is a "connection" page, showing publications Elizabeth Bayliss has written about Dementia.
Connection Strength
2.253
-
Perspectives on Deprescribing Communication in Primary Care. J Gen Intern Med. 2021 04; 36(4):1122.
Score: 0.658
-
Designing a Primary Care-Based Deprescribing Intervention for Patients with Dementia and Multiple Chronic Conditions: a Qualitative Study. J Gen Intern Med. 2020 12; 35(12):3556-3563.
Score: 0.628
-
Ethical Aspects of Physician Decision-Making for Deprescribing Among Older Adults With Dementia. JAMA Netw Open. 2023 10 02; 6(10):e2336728.
Score: 0.196
-
Willingness of older people living with dementia and mild cognitive impairment and their caregivers to have medications deprescribed. Age Ageing. 2023 01 08; 52(1).
Score: 0.186
-
Transforming Dementia Care Through Pragmatic Clinical Trials Embedded in Learning Healthcare Systems. J Am Geriatr Soc. 2020 07; 68 Suppl 2:S43-S48.
Score: 0.156
-
The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial. Trials. 2020 Jun 18; 21(1):542.
Score: 0.156
-
Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study. Drugs Aging. 2019 03; 36(3):289-297.
Score: 0.142
-
Medication Profiles of Patients with Cognitive Impairment and High Anticholinergic Burden. Drugs Aging. 2018 03; 35(3):223-232.
Score: 0.133